MRI prior to commencing bevacizumab

Coronal T1 C+
Modality: MRI (T1 C+)

- “ In response to the anti-angiogenic chemotherapy (bevacizumab), the post-treatment MRI shows significant reduction in enhacement, mass affect and t...”

View full size version of Pseudoresponse to bevacizumab in high grade glioma

Updating… Please wait.

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.